Instead of having expanded GLP-1 coverage built into Part D plans, CMS has created a bridge program where coverage will be provided outside of Part D through 2027
That's always been the case, and that fact...
Ozempic delivers major weight loss in adults over 65, study finds Date: May 11, 2026 Source: European Association for the Study of Obesity Summary: A major new analysis suggests semaglutide (Ozempic, Wegovy) works remarkably well in adults over 65, helping many lose substantial amounts of weight while improving heart and metabolic health
You can tell that these signs are happening if: Your appetite comes back before your next injection
Argenx is running Phase 3 studies of empasiprubart, which acts at a different point in the cascade
PlexusDx compounds tirzepatide to clinical specifications and pairs injections with virtual coaching, labs, and genetic testingcreating a comprehensive weight-management platform insurance alone cannot match